 |
International
Diabetes Federation calls for global action to keep all children
with diabetes alive |
| |
The International Diabetes Federation announced
today that it is bringing together key opinion leaders to push
for action to secure care for the thousands of children with diabetes
in developing countries without access (IDF) |
| |
|
|
Levels
Of Key Hormone During First Trimester Of Pregnancy Could Lead
To Earlier Diagnosis Of Gestational Diabetes |
| |
New research shows women who develop diabetes
during pregnancy (gestational diabetes mellitus) have reduced levels
of an insulin-sensitive hormone, adiponectin, as early as nine
weeks into the pregnancy (National Diabetes Support Team) |
| |
|
|
Diabetes
screening brings huge cut in CVD risk |
| |
Screening for diabetes and treating newly identified
cases can have a dramatic effect at reducing cardiovascular risk,
new research concludes (PULSE) |
| |
|
|
FDA
review of Takeda's alogliptin will not be finished on time |
| |
Takeda Pharmaceutical Co is going to have to
wait a bit longer to market alogliptin after US regulators said
they need more time to evaluate the Japanese drugmaker’s experimental type 2 diabetes drug (PharmaTimes) |
| |
|
|
Sector
Snap: Diabetes drug developers gain ground |
| |
A regulatory delay for Takeda Pharmaceuticals
developing diabetes drug alogliptin helped boost shares of competitor
Merck & Co. Monday, highlighting the competitive nature of diabetes drug development
within the pharmaceutical and biotech sectors (Business Week) |
| |
|
